126 related articles for article (PubMed ID: 2357253)
1. Monitoring of tumor necrosis factor therapy with neopterin.
Peters KM; Dommaschk J; Grundmann R; Schaadt M; Schicha H
Arzneimittelforschung; 1990 Apr; 40(4):508-10. PubMed ID: 2357253
[TBL] [Abstract][Full Text] [Related]
2. A study of interactions among markers of macrophage functions in metastatic solid tumors: neopterin levels in relation to those of tumor necrosis factor-alpha and of soluble interleukin-2 receptors.
Lissoni P; Brivio F; Fumagalli L; Galimberti C; Cataldo M; Marsili MT; Brivio O; Barni S; Tancini G; Angelini A
J Biol Regul Homeost Agents; 1994; 8(1):32-5. PubMed ID: 7976492
[TBL] [Abstract][Full Text] [Related]
3. Effects of granulocyte-macrophage colony stimulating factor on soluble interleukin-2 receptor serum levels and their relation to neopterin and tumor necrosis factor-alpha in cancer patients.
Crispino S; Lissoni P; Ardizzoia A; Rovelli F; Perego MS; Grassi MG; Barni S; Pittalis S; Tancini G
J Biol Regul Homeost Agents; 1993; 7(3):92-4. PubMed ID: 8135145
[TBL] [Abstract][Full Text] [Related]
4. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
5. Plasma elastase-alpha 1-antitrypsin, neopterin, tumor necrosis factor, and soluble interleukin-2 receptor after prolonged exercise.
Dufaux B; Order U
Int J Sports Med; 1989 Dec; 10(6):434-8. PubMed ID: 2628363
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis.
Nassonov EL; Samsonov MY; Tilz GP; Beketova TV; Semenkova EN; Baranov A; Wachter H; Fuchs D
J Rheumatol; 1997 Apr; 24(4):666-70. PubMed ID: 9101499
[TBL] [Abstract][Full Text] [Related]
7. [Studies of the relevance of the tumor marker neopterin for therapeutic decisions and follow-up of breast cancer].
Hacker I; Lauterbach H; Kob D
Radiobiol Radiother (Berl); 1989; 30(6):521-6. PubMed ID: 2608892
[TBL] [Abstract][Full Text] [Related]
8. [Activation of cellular immunity in Wegener's granulomatosis: a study of neopterin, interleukin-2 receptors and tumor necrosis factor].
Nasonov EL; Samsonov MIu; Tilz GP; Beketova TV; Semenkova EN; Mukhin NA; Baranov AA; Wachter H; Fuchs D
Ter Arkh; 1996; 68(11):67-70. PubMed ID: 9045386
[No Abstract] [Full Text] [Related]
9. The relationship between gut-derived endotoxemia and tumor necrosis factor, neopterin: experimental and clinical studies.
Sheng Z; Yao Y; Yu Y
Chin Med J (Engl); 1997 Jan; 110(1):30-5. PubMed ID: 9594318
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor in advanced gastrointestinal neoplasms. A clinical trial with a focus on haematological effects.
Muc-Wierzgoń M; Baranowski M; Madej K
Haematologia (Budap); 1996; 27(2):85-92. PubMed ID: 14651225
[TBL] [Abstract][Full Text] [Related]
11. [Serum neopterin in Behçet's disease].
Samsonov MIu; Prokaeva TB; Madanat V; Alekberova ZS; Nasonov EL; Fuks D; Vakhter Kh
Klin Med (Mosk); 1995; 73(5):53-5. PubMed ID: 8815280
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal production of neopterin in aseptic meningo-encephalitis and multiple sclerosis.
Fredrikson S; Eneroth P; Link H
Clin Exp Immunol; 1987 Jan; 67(1):76-81. PubMed ID: 3621676
[TBL] [Abstract][Full Text] [Related]
13. Neopterin as a marker for activated cell-mediated immunity: application in malignant disease.
Reibnegger G; Fuchs D; Fuith LC; Hausen A; Werner ER; Werner-Felmayer G; Wachter H
Cancer Detect Prev; 1991; 15(6):483-90. PubMed ID: 1782638
[TBL] [Abstract][Full Text] [Related]
14. [Tumor-induced anemia and markers of inflammation].
Morant R; Bacchus L; Meyer J; Riesen WF
Schweiz Med Wochenschr; 1994 Dec; 124(50):2267-71. PubMed ID: 7809592
[TBL] [Abstract][Full Text] [Related]
15. [Neopterin determination in the screening for spongiosa donors].
Peters KM; Leusch HG; Bruchhausen B; Schilgen M; Markos-Pusztai S
Z Orthop Ihre Grenzgeb; 1990; 128(5):453-6. PubMed ID: 2147332
[TBL] [Abstract][Full Text] [Related]
16. Neopterin and interferon gamma serum levels in renal allograft recipients.
Khoss AE; Balzar E; Steger H; Howanietz H; Wladika W; Hamilton G; Woloszczuk W
Child Nephrol Urol; 1988-1989; 9(1-2):46-9. PubMed ID: 3150820
[TBL] [Abstract][Full Text] [Related]
17. [Liberation of neopterin after lung resecting interventions with and without bronchial carcinoma].
Gebhard F; Lenz J; Brückner UB
Chirurg; 1996 Jul; 67(7):725-9. PubMed ID: 8776545
[TBL] [Abstract][Full Text] [Related]
18. [Neopterin as a marker of aspecific immunostimulation with Propionibacterium avidum KP-40 in patients with gastrointestinal tumors. A prospective randomized study].
Peters KM; Bornhofen B; Grundmann R; Ko HL; Beuth J; Waters W; Pichlmaier H; Pulverer G
Med Klin (Munich); 1990 Jul; 85(7):421-4. PubMed ID: 2385207
[TBL] [Abstract][Full Text] [Related]
19. Effects of etanercept on urine neopterin levels in patients with psoriasis in a controlled, open-label study.
Koc E; Tunca M; Akgul EO; Akar A; Kurt Y; Kurumlu Z; Erbil K; Kilic S
J Dermatol; 2009 Apr; 36(4):191-6. PubMed ID: 19348656
[TBL] [Abstract][Full Text] [Related]
20. [Neopterin: marker of cellular immunity activation in idiopathic inflammatory myopathy].
Nasonov EL; Samsonov MI; Shtutman VZ; Gekht BM; Gurkina GT; Tilz GP; Guseva NG; Fuchs D; Wachter H
Klin Med (Mosk); 1997; 75(2):47-51. PubMed ID: 9157218
[No Abstract] [Full Text] [Related]
[Next] [New Search]
